AN INVESTIGATION INTO FACTORS INFLUENCING REIMBURSEMENT TIMELINES OF NEW MEDICINES IN IRELAND

被引:0
|
作者
Copeland, C. [1 ]
Dooley, B. [1 ]
Hernon, M. [1 ]
Tracey, M. [2 ]
机构
[1] AXIS Healthcare Consulting Ltd, Dublin D, Ireland
[2] AXIS Healthcare Consulting Ltd, Dublin 2, Ireland
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PNS71
引用
收藏
页码:S655 / S655
页数:1
相关论文
共 50 条
  • [1] EXPLORING TIMELINES FOR NEW MEDICINES REIMBURSED IN IRELAND IN 2021
    McLoughlin, D.
    Copeland, C.
    Dooley, B.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S262 - S262
  • [2] HTA AND REIMBURSEMENT TIMELINES IN THE REPUBLIC OF IRELAND
    Liu, X.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S317 - S317
  • [3] AN ANALYSIS OF THE TIMELINES THROUGHOUT THE REIMBURSEMENT PATHWAY FOR DRUGS IN IRELAND
    Connolly, E.
    Lamrock, F.
    O'Donnell, H.
    Walsh, C.
    Tilson, L.
    Barry, M.
    [J]. VALUE IN HEALTH, 2018, 21 : S191 - S191
  • [4] INSIGHTS INTO REIMBURSEMENT RATES AND TIMELINES FOR ORPHAN DRUGS IN IRELAND
    Marsh, S. E.
    [J]. VALUE IN HEALTH, 2019, 22 : S726 - S726
  • [5] TIME TO REIMBURSEMENT IN IRELAND; UTILIZING REGRESSION ANALYSIS TO ASSESS FACTORS CONTRIBUTING TO OVERALL TIMELINES
    McLoughlin, D.
    Gribbon, E.
    Dooley, B.
    Hernon, M.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S283 - S283
  • [6] MARKET AUTHORIZATION ( MA) AND REIMBURSEMENT: ANALYSIS OF THE POST-MA TIMELINES AND THE ACCESS TO NEW MEDICINES IN BELGIUM
    Arickx, F.
    Pierlet, M.
    Soete, E.
    VanHaeren, E.
    Verplanken, P.
    Van Wilder, P.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A366 - A366
  • [7] ACCESS AND FACTORS INFLUENCING REIMBURSEMENT DECISION OF PERSONALIZED MEDICINES'S COMPANION DIAGNOSTIC TEST
    Jirawutkornkul, N.
    Thathong, T.
    Anantachoti, P.
    [J]. VALUE IN HEALTH, 2018, 21 : S57 - S57
  • [8] Factors Influencing Delays in Patient Access to New Medicines in Canada: A Retrospective Study of Reimbursement Processes in Public Drug Plans
    Salek, Sam
    Hoskyn, Sarah Lussier
    Johns, Jeffrey Roy
    Allen, Nicola
    Sehgal, Chander
    [J]. FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [9] Cost and public reimbursement of cancer medicines in the UK and the Republic of Ireland
    David O’Reilly
    Ronan McLaughlin
    Cian Ronayne
    Anne Marie De Frein
    Bojan Macanovic
    Ryan W. Chu
    Sinead A. Noonan
    Roisin M. Connolly
    Derek G. Power
    Richard M. Bambury
    Seamus O’Reilly
    Dearbhaile Catherine Collins
    [J]. Irish Journal of Medical Science (1971 -), 2023, 192 : 541 - 548
  • [10] Cost and public reimbursement of cancer medicines in the UK and the Republic of Ireland
    Reilly, David O.
    McLaughlin, Ronan
    Ronayne, Cian
    De Frein, Anne Marie
    Macanovic, Bojan
    Chu, Ryan W.
    Noonan, Sinead A.
    Connolly, Roisin M.
    Power, Derek G.
    Bambury, Richard M.
    Reilly, Seamus O.
    Collins, Dearbhaile Catherine
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (02) : 541 - 548